Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymphatic vessels and lymph node macrophages constitute a critical anatomical and functional unit of the immune and circulatory systems. Lymphatic vessels are specialized endothelial tubes that maintain tissue fluid balance and transport antigens and immune cells to regional lymph nodes [1]. Within these nodes, specific macrophage subsets, particularly subcapsular sinus macrophages, serve as essential filters that capture pathogens and initiate adaptive immune responses [2]. This system is frequently exploited by metastatic cancer cells for dissemination and is a primary site for vaccine-induced immune activation [3]. Pharmacological intervention often focuses on inhibiting vessel growth (lymphangiogenesis) in malignancy or utilizing the lymphatic route for targeted delivery of immunotherapeutics [4]. Understanding the interplay between lymphatic drainage and macrophage-mediated antigen presentation is vital for developing effective immunotherapies and preventing tumor spread. Key molecular markers for these components include LYVE-1 and VEGFR-3 for vessels, and CD169 for specific macrophage populations [5].
Pharmacological agents targeting this system primarily function by inhibiting lymphangiogenesis through the blockade of the VEGFR-3 signaling pathway or by modulating lymphocyte trafficking via sphingosine-1-phosphate (S1P) receptor antagonism.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymphatic vessels and lymph node macrophages (None).